Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Stage of Care
1.2.3. End-use
1.3. Estimates and forecasts timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased database
1.5.2. GVR’s internal database
1.5.3. Secondary sources
1.5.4. Primary research
1.5.5. Details of primary research
1.6. Information or Data Analysis
1.5.1. Data analysis models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity flow analysis (Model 1)
1.8.2. Approach 1: Commodity flow approach
1.8.3. Volume price analysis (Model 2)
1.8.4. Approach 2: Volume price analysis
1.9. List of Secondary Sources
1.10. List of Primary Sources
1.11. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology
2.2.2. Stage of Care
2.2.3. End-use outlook
2.3. Competitive Insights
Chapter 3. U.S. Breast Cancer Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of breast cancer
3.2.1.2. Government initiatives and screening programs
3.2.1.3. Expansion of imaging centers
3.2.2. Market Restraint Analysis
3.2.2.1. High Equipment Costs
3.2.2.2. Maintenance costs
3.3. Breast Cancer Imaging Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.4. Breast Cancer Imaging Market: Number of Procedures
3.5. Breast Cancer Imaging Market: Average Procedure Pricing
Chapter 4. U.S. Breast Cancer Imaging Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Breast Cancer Imaging Market: Technology Movement Analysis
4.3. Breast Cancer Imaging Market by Technology Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Mammography System (2D,3D)
4.5.1. Mammography System (2D,3D) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Magnetic Resonance Imaging (MRI)-based Systems
4.6.1. Magnetic Resonance Imaging (MRI)-based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Nuclear Medicine- Based Systems
4.7.1. Nuclear Medicine-Based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Ultrasound-Based Systems
4.8.1. Ultrasound-Based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9. Ultrasound-Based Systems
4.9.1. Ultrasound-Based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.10. Others
4.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Breast Cancer Imaging Market: Stage of Care Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Breast Cancer Imaging Market: Stage of Care Movement Analysis
5.3. Breast Cancer Imaging Market by Stage of Care Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Diagnostics
5.5.1. Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Pre-treatment Planning
5.6.1. Pre-treatment Planning Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Monitoring
5.7.1. Monitoring Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
5.8. Surveillance (Follow-Up)
5.8.1. Surveillance (Follow-Up) Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
Chapter 6. U.S. Breast Cancer Imaging Market: End-use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Breast Cancer Imaging Market: End-use Movement Analysis
6.3. Breast Cancer Imaging Market by End-use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Diagnostic Imaging Centers
6.6.1. Diagnostic Imaging Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Breast Care Centers
6.7.1. Breast Care Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Others
6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. Holigic, Inc.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. GE Healthcare
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Siemens Healthineers
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Seno Medical
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. b-rayZ
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Analogic Corporation
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Icad, Inc
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Clairity, Inc.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Fujifilm
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. FONAR Corporation
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. Breast Cancer Imaging market, by technology specialty, (USD Million) 2021 - 2033
Table 4 U.S. Breast Cancer Imaging market, by stage of care, (USD Million) 2021 - 2033
Table 5 U.S. Breast Cancer Imaging market, by end-use, (USD Million) 2021 - 2033
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. Breast Cancer Imaging: market outlook
Fig. 9 U.S. Breast Cancer Imaging market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 U.S. Breast Cancer Imaging market driver impact
Fig. 15 U.S. Breast Cancer Imaging market restraint impact
Fig. 16 U.S. Breast Cancer Imaging market strategic initiatives analysis
Fig. 17 U.S. Breast Cancer Imaging market: technology movement analysis
Fig. 18 U.S. Breast Cancer Imaging market: technology outlook and key takeaways
Fig. 19 Mammography Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 Magnetic Resonance Imaging (MRI)–Based Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Nuclear Medicine–Based Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Ultrasound-Based Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 (USD Million)
Fig. 24 U.S. Breast Cancer Imaging market: stage of care movement analysis
Fig. 25 U.S. Breast Cancer Imaging market: stage of care outlook and key takeaways
Fig. 26 Diagnostic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Pre-treatment Planning market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Surveillance (Follow-Up) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Breast Cancer Imaging market, end- use outlook key takeaways (USD Million)
Fig. 31 Breast Cancer Imaging market end- use movement analysis (USD Million), 2024 & 2033
Fig. 32 Hospitals’ market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Diagnostic Imaging Centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Breast Care Centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Participant categorization- U.S. Breast Cancer Imaging market
Fig. 37 Market share of key market players- U.S. Breast Cancer Imaging market
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
